枣庄哪个癫痫医院比较好(滨州羊角风开始是什么症状) (今日更新中)

ROME, Sept. 27 (Xinhua) -- The 30th general assembly of the International Council for Science (ICSU) kicked off here on Tuesday to address key global challenges, featuring over 275 scientists and experts from all over the world.The goal of the four-day event, hosted for the first time in Rome by the National Research Center (CNR) as Italy's scientific member at ICSU, is to discuss how science can contribute to boosting sustainable development, fighting climate change, increasing well-being and health in the changing urban environment and tackling the side-effects of progress.At the official opening ceremony, CNR president Francesco Profumo stressed that scientific research was the key to solving all current crises."It's during times of crises that inventions, great strategies and discoveries are made," he said quoting Albert Einstein."Global cooperation is crucial in addressing society's needs. In the wake of the negative economic outlook we are witnessing research and technological transfer can turn into efficient instruments to guide countries towards a solid development giving us the tools to tackle with lucidity the great obstacles we face," observed Profumo.Appealing to both private and public institutions, Profumo thus urged to boost strategic partnerships between universities, governments and research centres."We must create a network of knowledge-sharing together with enterprises in order to multiply and better implement growth and well-being opportunities. But in order to do so concrete political decisions must be undertaken and financial resources are needed," he added.

HELSINKI, July 4 (Xinhua) -- A new Finnish research shows that sleeplessness may be hereditary, and insomniacs are more likely to die earlier than people with healthy sleep patterns.The research is the first to link insomnia with mortality risk, Finnish media reported on Monday.The research is conducted by the Institute of Occupational Health in collaboration with the University of Helsinki and the Finnish National Institute for Health and WelfareIn a large-scale twin study, the Finnish researchers followed the health status of 12,500 adult twin pairs during the years from 1990 to 2009. Twenty percent of the participants were suffering from sleeplessness symptoms, including difficulty in initiating sleep, nocturnal awakening and non-restorative sleep.The study found out that compared with unidentical twins, identical twins were more likely to suffer from similar insomnia symptoms. This finding indicates that genetic factors play a role in the formation of insomnia.Moreover, the participants were divided into three groups, according to their sleep qualities. Out of the participants, 48 percent were good sleepers, 40 percent average sleepers and 12 percent poor sleepers. The search result shows that insomnia-related symptoms may increase mortality risk.In addition, compared with good sleepers, 7 percent of the women and 22 percent of the men who were average sleepers were more likely to die earlier; and poor sleepers were 1.5 times more likely to die earlier.According to the researchers, sleeplessness is a common health problem among working-age cohort. Chronic sleeplessness raises the risk of many illnesses and accidents, and thus weakens people's quality of life and ability to operate properly.The experts suggest that insomniacs should seek medical treatment in time, and chronic insomnia patients should be better treated with non-drug therapy.

WARSAW, June 2 (Xinhua) -- A possible second E. coli infection patient has been hospitalized in Szczecin, northwestern Poland, Health Minister Ewa Kopacz said Thursday.The man, who recently returned to Poland from Germany, has been diagnosed with exudative diarrhea and is currently being tested for E. coli bacteria.Poland's first E. coli case, a 29-year-old woman permanently residing in Germany and diagnosed with the bacteria over a week ago, is currently in the same hospital.Kopacz said sanitary teams were running E. coli checks countrywide, especially on marketplaces and in warehouses.The E. coli epidemic originated in Germany, where it has taken 17 lives. One death has so far occurred in Sweden, bringing the total death toll to 18.

People look at a W154 Mercedes Benz racing car at a vintage car show marking the German car maker's 125 anniversary at the former Tempelhof airport in Berlin, August 27, 2011.

BEIJING, Sept. 14 (Xinhuanet) -- The U.S. Food and Drug Administration (FDA) on Monday announced a recall on a drug infusion pump of Medtronic, the Associated Press reported.The recalled drug pump was called "SynchroMed II", including models of 8637-20 and 8637-40, distributed between 2004 and July 2011.Drug infusion pump was used to deliver the drugs for patients to treat chronic pain, spasms as well as other conditions.The pumps' malfunction could put patients in the risk of either recurrent or withdrawal symptoms, which could be life-threatening, FDA warned.There were 55 reported cases and one death related to the drug withdrawal, among a total 139,653 SynchroMed II pump implants worldwide, FDA notified.The problem was due to a film within the pump's battery that could stop the therapy, FDA said.Medtronic, the U.S. medical technology company based in Minneapolis, is not recommending patients to remove the pumps, but instead, encourage patients to contact their doctor if they hear the device alarm.

来源：资阳报